Nanami Irie
Overview
Explore the profile of Nanami Irie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Irie N, Mizoguchi K, Warita T, Nakano M, Sasaki K, Tashiro J, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540310
Metastatic melanoma has a very poor prognosis. Statins, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) inhibitors, are cholesterol-lowering agents with a potential for cancer treatment. The inhibition of HMGCR by statins, however, induces...
2.
Ishikawa T, Irie N, Tashiro J, Osaki T, Warita T, Warita K, et al.
Vet Comp Oncol
. 2023 Dec;
22(1):156-161.
PMID: 38044042
Canine oral melanoma is a highly malignant cancer with a poor prognosis. Statins, commonly used drugs for treating dyslipidemia, exhibit pleiotropic anticancer effects and marked anti-proliferative effects against melanoma cells....
3.
Tashiro J, Sugiura A, Warita T, Irie N, Cahyadi D, Ishikawa T, et al.
J Pharmacol Sci
. 2023 Sep;
153(3):104-112.
PMID: 37770151
Statins, which are cholesterol synthesis inhibitors, are well-known therapeutics for dyslipidemia; however, some studies have anticipated their use as anticancer agents. However, epithelial cancer cells show strong resistance to statins...
4.
Zhou Y, Tashiro J, Kamatani S, Irie N, Suzuki A, Ishikawa T, et al.
Biochem Biophys Res Commun
. 2023 Aug;
677:13-19.
PMID: 37541087
Statins are cholesterol-lowering drugs that have exhibited potential as cancer therapeutic agents. However, as some cancer cells are resistant to statins, broadening an anticancer spectrum of statins is desirable. The...
5.
Irie N, Warita K, Tashiro J, Zhou Y, Ishikawa T, Oltvai Z, et al.
Heliyon
. 2023 Jul;
9(7):e18017.
PMID: 37501994
Statins have anticancer effects and may be used as anticancer agents via drug repositioning. In reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays, the internal reference gene must not be affected...
6.
Cahyadi D, Warita T, Irie N, Mizoguchi K, Tashiro J, Hosaka Y, et al.
Adipocyte
. 2023 Jul;
12(1):2235081.
PMID: 37436361
Normalization is a crucial step in gene expression analysis to avoid misinterpretation. Reverse transcription-quantitative polymerase chain reaction was used to measure the expression of 10 candidate housekeeping genes in non-differentiated...
7.
Warita T, Irie N, Zhou Y, Tashiro J, Sugiura A, Oltvai Z, et al.
Life Sci
. 2022 Dec;
312:121249.
PMID: 36455649
Aims: Statins, cholesterol-lowering drugs, are potential therapeutic agents for inhibiting cancer proliferation. However, the mechanisms that mediate the effects of statins, the homeostatic responses of tumor cells to statin therapy,...